PTC Therapeutics, Inc.

PTC Therapeutics, Inc.

PTC Therapeutics, Inc. company focuses on post-transcriptional control (PTC) of RNA to develop new drugs. Its GEMS (gene expression modulation by small molecules) technology allows the firm to quickly identify compounds that regulate protein synthesis and therefore could control a disease or condition. PTC Therapeutics is looking to discover, develop, and commercialize new therapies for genetic disorders (including muscular dystrophy and cystic fibrosis), cancer, and infectious diseases (especially hepatitis C).

Contact Details

Office Address

PTC Therapeutics, Inc.
100 Corporate Court
South Plainfield, NJ, USA 07080-2449
Phone: (908) 222-7000
Fax: (908) 222-7231

Executives

Chairman

Michael Schmertzler

President, CEO, and Director

Stuart W. Peltz

Business Reviews for PTC Therapeutics, Inc.

Related Companies